Article
Unraveling MASLD Through the Use of Omics Technologies
2025-01-07
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD), now referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is the most prevalent liver disorder globally, linked to obesity, type 2 diabetes, and cardiovascular risk. Understanding its potential progression, from simple steatosis to cirrhosis and hepatocellular carcinoma (HCC), is crucial for patient management and treatment strategies. The disea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b4a6095e-ec29-55a6-85b4-58c46a5c8862
- DOI
- 10.20944/preprints202501.0541.v1
